FINAL REGN DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Regeneron Therapeutics, Inc. Investors to Join the Class Action Lawsuit
Portfolio Pulse from
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Regeneron Pharmaceuticals, Inc. for alleged violations of federal securities laws. The lawsuit targets those who acquired Regeneron securities between November 2, 2023, and October 30, 2024.
March 09, 2025 | 11:15 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. for alleged securities law violations, potentially impacting investors who acquired shares between November 2, 2023, and October 30, 2024.
The lawsuit could lead to financial penalties or settlements, negatively impacting Regeneron's stock price. Legal issues often create uncertainty, which can result in short-term downward pressure on stock prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100